Conference
ACTIVATE: A phase 3, randomized, multicenter, double-blind, placebo-controlled study of mitapivat in adults with Pyruvate kinase deficiency who are not regularly transfused
Authors
Al-Samkari H; Galacteros F; Glenthoj A; Rothman JA; Andres O; Grace RF; Arias MM; Layton DM; Onodera K; Verhovsek M
Volume
44
Pagination
pp. 40-40
Publisher
KARGER
Publication Date
September 1, 2021
Conference proceedings
ONCOLOGY RESEARCH AND TREATMENT
ISSN
2296-5270